Cargando…
Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms
To define the role of spleen stiffness (SS) and liver stiffness (LS) in myelofibrosis and other Philadelphia (Ph)-negative myeloproliferative neoplasms (MPNs), we studied, by ultrasonography (US) and elastography (ES), 70 consecutive patients with myelofibrosis (MF) (no.43), essential thrombocythemi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408647/ https://www.ncbi.nlm.nih.gov/pubmed/32650390 http://dx.doi.org/10.3390/jcm9072149 |
_version_ | 1783567879570980864 |
---|---|
author | Benedetti, Edoardo Tavarozzi, Rita Morganti, Riccardo Bruno, Benedetto Bramanti, Emilia Baratè, Claudia Balducci, Serena Iovino, Lorenzo Ricci, Federica Ricchiuto, Vittorio Buda, Gabriele Galimberti, Sara |
author_facet | Benedetti, Edoardo Tavarozzi, Rita Morganti, Riccardo Bruno, Benedetto Bramanti, Emilia Baratè, Claudia Balducci, Serena Iovino, Lorenzo Ricci, Federica Ricchiuto, Vittorio Buda, Gabriele Galimberti, Sara |
author_sort | Benedetti, Edoardo |
collection | PubMed |
description | To define the role of spleen stiffness (SS) and liver stiffness (LS) in myelofibrosis and other Philadelphia (Ph)-negative myeloproliferative neoplasms (MPNs), we studied, by ultrasonography (US) and elastography (ES), 70 consecutive patients with myelofibrosis (MF) (no.43), essential thrombocythemia (ET) (no.10), and polycythemia vera (PV) (no.17). Overall, the median SS was not different between patients with MF and PV (p = 0.9); however, both MF and PV groups had significantly higher SS than the ET group (p = 0.011 and p = 0.035, respectively) and healthy controls (p < 0.0001 and p = 0.002, respectively). In patients with MF, SS values above 40 kPa were significantly associated with worse progression-free survival (PFS) (p = 0.012; HR = 3.2). SS also correlated with the extension of bone marrow fibrosis (BMF) (p < 0.0001). SS was higher in advanced fibrotic stages MF-2, MF-3 (W.H.O. criteria) than in pre-fibrotic/early fibrotic stages (MF-0, MF-1) (p < 0.0001) and PFS was significantly different in the two cohorts, with values of 63% and 85%, respectively (p = 0.038; HR = 2.61). LS significantly differed between the patient cohort with MF and healthy controls (p = 0.001), but not between the patient cohorts with ET and PV and healthy controls (p = 0.999 and p = 0.101, respectively). We can conclude that organ stiffness adds valuable information to the clinical work-up of MPNs and could be employed to define patients at a higher risk of progression. |
format | Online Article Text |
id | pubmed-7408647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74086472020-08-13 Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms Benedetti, Edoardo Tavarozzi, Rita Morganti, Riccardo Bruno, Benedetto Bramanti, Emilia Baratè, Claudia Balducci, Serena Iovino, Lorenzo Ricci, Federica Ricchiuto, Vittorio Buda, Gabriele Galimberti, Sara J Clin Med Article To define the role of spleen stiffness (SS) and liver stiffness (LS) in myelofibrosis and other Philadelphia (Ph)-negative myeloproliferative neoplasms (MPNs), we studied, by ultrasonography (US) and elastography (ES), 70 consecutive patients with myelofibrosis (MF) (no.43), essential thrombocythemia (ET) (no.10), and polycythemia vera (PV) (no.17). Overall, the median SS was not different between patients with MF and PV (p = 0.9); however, both MF and PV groups had significantly higher SS than the ET group (p = 0.011 and p = 0.035, respectively) and healthy controls (p < 0.0001 and p = 0.002, respectively). In patients with MF, SS values above 40 kPa were significantly associated with worse progression-free survival (PFS) (p = 0.012; HR = 3.2). SS also correlated with the extension of bone marrow fibrosis (BMF) (p < 0.0001). SS was higher in advanced fibrotic stages MF-2, MF-3 (W.H.O. criteria) than in pre-fibrotic/early fibrotic stages (MF-0, MF-1) (p < 0.0001) and PFS was significantly different in the two cohorts, with values of 63% and 85%, respectively (p = 0.038; HR = 2.61). LS significantly differed between the patient cohort with MF and healthy controls (p = 0.001), but not between the patient cohorts with ET and PV and healthy controls (p = 0.999 and p = 0.101, respectively). We can conclude that organ stiffness adds valuable information to the clinical work-up of MPNs and could be employed to define patients at a higher risk of progression. MDPI 2020-07-08 /pmc/articles/PMC7408647/ /pubmed/32650390 http://dx.doi.org/10.3390/jcm9072149 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Benedetti, Edoardo Tavarozzi, Rita Morganti, Riccardo Bruno, Benedetto Bramanti, Emilia Baratè, Claudia Balducci, Serena Iovino, Lorenzo Ricci, Federica Ricchiuto, Vittorio Buda, Gabriele Galimberti, Sara Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms |
title | Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms |
title_full | Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms |
title_fullStr | Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms |
title_full_unstemmed | Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms |
title_short | Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms |
title_sort | organ stiffness in the work-up of myelofibrosis and philadelphia-negative chronic myeloproliferative neoplasms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408647/ https://www.ncbi.nlm.nih.gov/pubmed/32650390 http://dx.doi.org/10.3390/jcm9072149 |
work_keys_str_mv | AT benedettiedoardo organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT tavarozzirita organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT morgantiriccardo organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT brunobenedetto organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT bramantiemilia organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT barateclaudia organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT balducciserena organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT iovinolorenzo organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT riccifederica organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT ricchiutovittorio organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT budagabriele organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms AT galimbertisara organstiffnessintheworkupofmyelofibrosisandphiladelphianegativechronicmyeloproliferativeneoplasms |